StockData

Lakefront Biotherapeutics vs TG Therapeutics

LKFT and TGTX side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How LKFT and TGTX compare

Lakefront Biotherapeutics grew revenue faster over the last twelve months (304% versus 76.1% for TG Therapeutics).

TG Therapeutics keeps more of each dollar of sales as profit, with a net margin of 55.2% compared with 28.8% at Lakefront Biotherapeutics.

TG Therapeutics scores higher on the StockData Score (9 against 7 for Lakefront Biotherapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricLKFTTGTX
Size and price
Market cap–$9.6B
Share price$34.39$62.71
Change, 1 year9.9%102%
Change, 5 years−29.6%162%
Beta (5Y)0.260.47
Employees452399
StockData Score
Total score79 (better)
Valuation score01 (better)
Growth score3 (better)2
Performance score24 (better)
Health score22
Dividend score00
Valuation
P/E–22.9×
P/S–12.0×
P/B–15.9×
EV/EBITDA–71.3×
P/FCF–552×
FCF yield–0.18%
Fair value–$60.66
Margin of safety–−3.4%
Growth
Revenue growth (TTM)304% (better)76.1%
Revenue growth, 5Y average18.4%427% (better)
Net income growth (TTM)333%630% (better)
EPS growth (TTM)335%641% (better)
Profitability
Gross margin97.3% (better)82.4%
Operating margin26.5% (better)17.1%
Net margin28.8%55.2% (better)
FCF margin−24.4%2.2% (better)
Return on equity–100%
Return on invested capital–27.8%
Financial health
Debt / equity–1.23
Net debt / EBITDA–0.98
Interest coverage285× (better)3.6×
Current ratio20.15 (better)4.27
Altman Z-score–6.07
Piotroski F-score7 (better)4
Dividends and buybacks
Buyback yield–1.9%
Shareholder yield–1.9%
Ownership
Held by institutions48.6%72.6%
Held by insiders45.1%16.1%
Insider net buying, 12 months–−$275K
Short interest, % of float–22.4%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.